Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07586059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay

Study acronym: CIILOS
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2026 → Dec 31, 2027
See other at-risk trials from Karolinska Institutet

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Start date: Aug 1, 2026 to Nov 1, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Eligibility criteria expanded, about 3 words
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This large national cohort study, including over 500,000 patients, where around 5% are treated with continuous renal replacement therapy (CRRT) , aims to evaluate the association between time to initiation of CRRT and intensive care unit (ICU) length of stay (LOS).
Trial Details
NCT Number NCT07586059
Lead Sponsor Karolinska Institutet
Conditions
(from sponsor)		 AKI - Acute Kidney Injury, Critical Illness
Related terms Acute Kidney Injury, Critical Illness
Enrollment 500,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov